Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- Check3 days agoChange DetectedThe history gains a new revision entry v3.5.5 and removes the previous v3.5.4, reflecting an updated record version.SummaryDifference0.1%

- Check10 days agoChange DetectedNo additions or deletions are present in the change data. This indicates that the study record history displayed here has not been modified in the provided snapshot.SummaryDifference0.1%

- Check17 days agoChange DetectedNo textual changes were detected in the record history data for NCT04959032. The page text remains as shown in the current context.SummaryDifference0.1%

- Check25 days agoChange DetectedA new revision entry, v3.5.4, was added to the page history, and the previous v3.5.3 entry was removed. This represents a small update to the page's revision metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedUpdates the displayed ClinicalTrials.gov revision/version indicator from v3.5.2 to v3.5.3 for this page.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded a new revision entry for v3.5.2 and removed the prior v3.5.0 revision.SummaryDifference0.1%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.